Literature DB >> 26860501

Intensity is a subjective construct.

L M Giangregorio1,2,3, A Papaioannou4, A Heinonen5, A M Cheung6, J Laprade7, M C Ashe8, N J MacIntyre9, K Shipp10, S McGill11, J Ravi12, H Keller11,13, J D Wark14.   

Abstract

Mesh：

Year:  2016        PMID： 26860501      PMCID： PMC5094884          DOI： 10.1007/s00198-016-3507-9

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  3 in total

1.  Too Fit To Fracture: outcomes of a Delphi consensus process on physical activity and exercise recommendations for adults with osteoporosis with or without vertebral fractures.

Authors:  L M Giangregorio; S McGill; J D Wark; J Laprade; A Heinonen; M C Ashe; N J MacIntyre; A M Cheung; K Shipp; H Keller; R Jain; A Papaioannou
Journal:  Osteoporos Int       Date:  2014-12-16       Impact factor: 4.507

2.  Too Fit To Fracture: exercise recommendations for individuals with osteoporosis or osteoporotic vertebral fracture.

Authors:  L M Giangregorio; A Papaioannou; N J Macintyre; M C Ashe; A Heinonen; K Shipp; J Wark; S McGill; H Keller; R Jain; J Laprade; A M Cheung
Journal:  Osteoporos Int       Date:  2013-11-27       Impact factor: 4.507

3.  Heavy resistance training is safe and improves bone, function, and stature in postmenopausal women with low to very low bone mass: novel early findings from the LIFTMOR trial.

Authors:  S L Watson; B K Weeks; L J Weis; S A Horan; B R Beck
Journal:  Osteoporos Int       Date:  2015-08-05       Impact factor: 4.507
  3 in total
  2 in total

1.  Response to Giangregorio et al.: "Intensity is a subjective construct".

Authors:  B R Beck; S L Watson; L Weis; S A Horan; B K Weeks
Journal:  Osteoporos Int       Date:  2016-03-07       Impact factor: 4.507

Review 2.  Which strength and balance activities are safe and efficacious for individuals with specific challenges (osteoporosis, vertebral fractures, frailty, dementia)?: A Narrative review.

Authors:  Dawn A Skelton; Alexandra Mavroeidi
Journal:  J Frailty Sarcopenia Falls       Date:  2018-06-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.